Mast cells and angiogenesis
โ Scribed by Yuji Hiromatsu; Shuji Toda
- Publisher
- John Wiley and Sons
- Year
- 2003
- Tongue
- English
- Weight
- 152 KB
- Volume
- 60
- Category
- Article
- ISSN
- 1059-910X
No coin nor oath required. For personal study only.
โฆ Synopsis
Abstract
There is much evidence that angiogenesis is related to mast cells. Mast cells accumulate in many angiogenesisโdependent situations, including tumor growth, rheumatoid arthritis, ovulation, would healing, and tissue repair. Several mast cell mediators are angiogenic and regulate endothelial cell proliferation and function. Stem cell factor, vascular endothelial growth factor, epidermal growth factor, basic fibroblast growth factor, and plateletโderived growth factor induce chemotactic migration of mast cells to sites of neovascularization. Mast cell products such as tryptase also degrade connective tissue matrix to provide space for neovascular sprouts. Angiogenesis has been proposed as a target for anticancer therapy and for treatment of inflammatory disorders such as rheumatoid arthritis. Future studies on the cascade of angiogenic events, including mast cellโtarget cell interaction, and various intracellular signaling pathways are indicated to provide a new approach for the treatment of cancer and inflammatory disorders and for tissue repair. Microsc. Res. Tech. 60:64โ69, 2003. ยฉ 2002 WileyโLiss, Inc.
๐ SIMILAR VOLUMES
## Abstract Tumor angiogenesis factor (TAF) elicits a strong vasoproliferative response when implanted upon the chorioallantoic membrane (CAM) of the chick embryo. This response is first observed stereomicroscopically 2โ3 days after implantation. A 40โfold increase in mast cell density is observed
Exposure to tumour cells has previously been shown to induce mast cells to degranulate and release heparin. Isolated mastsell granules were found to be mitogenic for endothelial cells in vitro. This effect was a property of mast-cell heparin, whose potency as a mitogen exceeded that of commercial he